← Back to Clinical Trials
Recruiting NCT06543420

The Role of Levator Ani Muscle Reconstruction Technology in Urinary Incontinence Recovery

Trial Parameters

Condition Prostate Cancer
Sponsor Peking University First Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 192
Sex MALE
Min Age 18 Years
Max Age 80 Years
Start Date 2024-07-22
Completion 2025-07-21
Interventions
lateral reconstructionposterior reconstruction

Brief Summary

This study is a single center, single blind, prospective randomized controlled trial. Patients undergoing robot assisted laparoscopic radical prostatectomy for prostate cancer were randomly divided into 1:1:1 groups, using lateral reconstruction, posterior reconstruction, or no reconstruction. Patients were followed up regularly after surgery and clinical data were collected, including daily use of urine pads, ICIQ-SF score, 24-hour urine leakage, I-QoL score, etc., to evaluate the improvement effect of lateral reconstruction on urinary control and the difference in effect between lateral reconstruction and posterior reconstruction, thereby improving the quality of life of prostate cancer patients after surgery.

Eligibility Criteria

Inclusion Criteria: * Diagnosed with prostate cancer and preoperative clinical stage of cT2\~T3aN0M0 * Complies with the indications for RARP surgery Exclusion Criteria: * History of urinary incontinence or urethral stricture * Previous prostate related surgical treatment * Contraindications for RARP surgery * The patient or their family members refuse to participate

Related Trials